Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT04053842
Overview
The study is a non-randomized, prospective trial of men scheduled for radical prostatectomy for treatment of prostate cancer as standard of care and will undergo a series of pre-operative multi-modality imaging studies. Pre-operative imaging will be correlated with actual pathology results and statistical modeling performed to determine the most informative imaging biomarkers in predicting cancer location and aggressiveness (Gleason Score).
Sponsor
Glenn Bauman
Phase
Phase 2
Contacts
Catherine Hildebrand, PhD
catherine.hildebrand@lhsc.on.ca
519-685-8500 ext 53535
Mena Gaed
mena.gaed@lhsc.on.ca
519-685-8500 ext 56601
ClinicalTrials.gov
NCT04053842Drug / Compound
Help us improve your experience